Genetic evidence for antagonism between Pak protein kinase and Rho1 small GTPase signaling in regulation of the actin cytoskeleton during Drosophila oogenesis

During Drosophila oogenesis, basally localized F-actin bundles in the follicle cells covering the egg chamber drive its elongation along the anterior-posterior axis. The basal F-actin of the follicle cell is an attractive system for the genetic analysis of the regulation of the actin cytoskeleton, and results obtained in this system are likely to be broadly applicable in understanding tissue remodeling. Mutations in a number of genes, including that encoding the p21-activated kinase Pak, have been shown to disrupt organization of the basal F-actin and in turn affect egg chamber elongation. pak mutant egg chambers have disorganized F-actin distribution and remain spherical due to a failure to elongate. In a genetic screen to identify modifiers of the pak rounded egg chamber phenotype several second chromosome deficiencies were identified as suppressors. One suppressing deficiency removes the rho1 locus, and we determined using several rho1 alleles that removal of a single copy of rho1 can suppress the pak phenotype. Reduction of any component of the Rho1-activated actomyosin contractility pathway suppresses pak oogenesis defects, suggesting that Pak counteracts Rho1 signaling. There is ectopic myosin light chain phosphorylation in pak mutant follicle cell clones in elongating egg chambers, probably due at least in part to mislocalization of RhoGEF2, an activator of the Rho1 pathway. In early egg chambers, pak mutant follicle cells have reduced levels of myosin phosphorylation and we conclude that Pak both promotes and restricts myosin light chain phosphorylation in a temporally distinct manner during oogenesis.     

Protein-lipid interactions glycophorin and dipalmitolyphosphatidylcholine.

The choline methyl groups of dipalmitoylphosphatidylcholine were enriched with ¹³C, and glycophorin extracted from human erythrocytes was included in bilayers of this phospholipid. At temperatures below the transition temperature, the ¹³C nuclear magnetic resonance spectra have two components, one sharp and one broad. The sharp signal is attributed to relatively “fluid” lipids in the immediate vicinity of the glycoprotein. In a defined ternary mixture consisting of ¹³C-labeled dipalmitoylphosphatidylcholine, dielaidoylphosphatidylcholine and glycophorin, the sharp ¹³C resonance signal disappears below the transition temperature of the mixture, indicating that the unsaturated lipid is preferentially associated with the glycoprotein under these conditions.     

Development of an Assay for Phospholipase C Using Column-Reconstituted, Extruded Phospholipid Vesicles

The reconstitution of heterotrimeric G proteins into phospholipid vesicles has been widely used for the measurement of PLC-beta activity in vitro. We have developed an improved and sensitive method for the assay of PLC-beta activity. This approach involves reconstitution of purified betagamma dimers into extruded phospholipid vesicles containing phosphatidylinositol 4, 5-bisphosphate and using a gel-filtration technique to separate the reconstituted vesicles from monodispersed betagamma dimers and the detergent used to solubilize G proteins. The method provides physical information about the partitioning of betagamma dimers into phospholipid vesicles and was used to examine the effect of different prenyl groups on the gamma subunits in the activation of PLC-beta. The beta1gamma1 dimer (containing the farnesyl group) and the beta1gamma2 dimer (containing the geranylgeranyl group) were purified from baculovirus-infected Sf9 insect cells and were found to partition equally into phospholipid vesicles. The beta1gamma2 dimer is more potent and effective in stimulating PLC-beta activity than the beta1gamma1 dimer. The EC50 values of betagamma dimers for the activation of PLC-beta determined with this method were lower than those determined by previous methodology, showing that betagamma subunits have a subnanomolar affinity for PLC-beta.     

Reconstitution of band 3, the erythrocyte anion exchange protein

Band 3, the erythrocyte membrane protein thought to be responsible for anion transport, was purified to near homogeneity using a Concanavalin A affinity column. Band 3 was then combined with egg lecithin, erythrocyte lipid, cholesterol, and glycophorin, the major erythrocyte sialoglycoprotein, to form vesicles capable of rapid sulfate transport. The transport activity was sensitive to prior treatment of the erythrocytes with pyridoxal phosphate-NaBH₄, a potent inhibitor of anion transport in these cells.     

Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channels

An initial SAR study on a series of apamin-displacing 2-aminothiazole K(Ca)2 channel blockers is described. Potent inhibitors such as N-(4-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (13) are disclosed, and for select members of the series, the relationship between the observed activity in a thallium flux, a binding and a whole-cell electrophysiology assay is presented.     

Receptor and G-protein-dependent regulation of turkey erythrocyte phosphoinositidase C

Several lines of experimental evidence indicate the involvement of a guanine nucleotide-dependent protein (G-protein) in the hormone-stimulated hydrolysis of phosphatidylinositol(4,5)-bisphosphate (PtdIns(4,5)P2). However, the shortcomings of available procedures for cell-free assay of hormone-stimulated phosphoinositidase C (PIC) have limited our current understanding of the molecular and mechanistic details of PIC regulation. We recently have proposed that turkey erythrocyte membranes may provide a valuable model system for studies of G-protein-dependent PtdIns(4,5)P2 hydrolysis. The membranes can be simply prepared from [3H]inositol-labelled erythrocytes and they contain a PIC activity that hydrolyses endogenous phosphoinositides and is exquisitively sensitive to guanine nucleotides. PtdIns(4,5)P2 is the principal substrate for this enzyme, there being relatively little direct hydrolysis of phosphatidylinositol 4-phosphate and no detectable hydrolysis of PtdIns. The membranes also contain a purinoceptor of the P2y subclass that is efficiently coupled to PtdIns(4,5)P2 hydrolysis both in intact cells and in the isolated membranes. 2-Methylthioadenosine trisphosphate (2-methyl-S-ATP), a specific P2y receptor agonist, has no effect upon PtdIns(4,5)P2 hydrolysis in the absence of guanine nucleotides, but greatly enhances both the potency and efficacy of PIC activation by guanine nucleotides such as GTP gamma S. GTP gamma S alone stimulates PIC activity only after a prolonged time-lag; the effect of increasing doses of 2-methyl-S-ATP is progressively to shorten this lag phase. These results suggest that the mechanism of G-protein activation involves acceleration of a nucleotide exchange reaction as has been demonstrated for the activation of adenylate cyclase in the same membrane preparation. As well as contributing valuable information on the substrate specificity of PIC and its mode of regulation by hormones, turkey erythrocytes provide a plentiful source of plasma membranes and may be useful for purification of the appropriate G-protein and PIC activities.     

Preliminary SAR studies on non-apamin-displacing 4-(aminomethylaryl)pyrrazolopyrimidine K(Ca) channel blockers

An exploratory SAR study on a series of potent, non-apamin-displacing 4-(aminomethylaryl)pyrazolopyrimidine K(Ca) channel blockers is described and their selectivity against K(Ca) channel subtypes is reported. The most potent analog, 5-chloro-N-(thiophen-2-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine (24) displayed sub-micromolar activity in both a thallium flux and whole-cell electrophysiology assay and did not displace apamin in a competitive binding study.     

Defining winter trophic habitat of juvenile Gulf Sturgeon in the Suwannee and Apalachicola rivermouth estuaries, acoustic telemetry investigations

Three automated listening post‐telemetry studies were undertaken in the Suwannee and Apalachicola estuaries to gain knowledge of habitats use by juvenile Gulf Sturgeons (Acipenser oxyrinchus desotoi) on winter feeding grounds. A simple and reliable method for external attachment of small acoustic tags to the dorsal fin base was developed using shrink‐tubing. Suspending receivers on masts below anchored buoys improved reception and facilitated downloading; a detection range of 500–2500 m was realized. In the Apalachicola estuary, juvenile GS stayed in shallow water (< 2 m) within the estuarine transition zone all winter in the vicinity of the Apalachicola River mouth. Juvenile GS high‐use areas did not coincide with high density benthic macrofauna areas from the most recent (1999) benthos survey. In the Suwannee estuary, juveniles ranged widely and individually throughout oligohaline to mesohaline subareas of the estuary, preferentially using mesohaline subareas seaward of Suwannee Reef (52% of acoustic detections). The river mouth subarea was important only in early and late winter, during the times of adult Gulf Sturgeon migrations (41% of detections). Preferred winter feeding subareas coincided spatially with known areas of dense macrofaunal benthos concentrations. Following a dramatic drop in air and water temperatures, juvenile GS left the river mouth and estuary, subsequently being detected 8 km offshore in polyhaline open Gulf of Mexico waters, before returning to the estuary. Cold‐event offshore excursions demonstrate that they can tolerate full‐salinity polyhaline waters in the open Gulf of Mexico, for at least several days at a time. For juvenile sturgeons, the stress and metabolic cost of enduring high salinity ( Jarvis et al., 2001 ; McKenzie et al., 2001 ; Singer and Ballantyne, 2002 ) for short periods in deep offshore waters seems adaptively advantageous relative to the risk of cold‐event mortality in shallow inshore waters of lower salinity. Thus, while juveniles can tolerate high salinities for days to weeks to escape cold events, they appear to make only infrequent use of open polyhaline waters. Throughout the winter foraging period, juvenile GS stayed primarily within the core area of Suwannee River mouth influence, extending about 12 km north and south of the river mouth, and somewhat seaward of Suwannee Reef (< 5 km offshore). None were detected departing the core area past either of the northern or southern acoustic gates, located 66 and 52 km distant from the river mouth, respectively.     

Development of selective agonists and antagonists of P2Y receptors

Although elucidation of the medicinal chemistry of agonists and antagonists of the P2Y receptors has lagged behind that of many other members of group A G protein-coupled receptors, detailed qualitative and quantitative structure–activity relationships (SARs) were recently constructed for several of the subtypes. Agonists selective for P2Y₁, P2Y₂, and P2Y₆ receptors and nucleotide antagonists selective for P2Y₁ and P2Y₁₂ receptors are now known. Selective nonnucleotide antagonists were reported for P2Y₁, P2Y₂, P2Y₆, P2Y₁₁, P2Y₁₂, and P2Y₁₃ receptors. At the P2Y₁ and P2Y₁₂ receptors, nucleotide agonists (5′-diphosphate derivatives) were converted into antagonists of nanomolar affinity by altering the phosphate moieties, with a focus particularly on the ribose conformation and substitution pattern. Nucleotide analogues with conformationally constrained ribose-like rings were introduced as selective receptor probes for P2Y₁ and P2Y₆ receptors. Screening chemically diverse compound libraries has begun to yield new lead compounds for the development of P2Y receptor antagonists, such as competitive P2Y₁₂ receptor antagonists with antithrombotic activity. Selective agonists for the P2Y₄, P2Y₁₁, and P2Y₁₃ receptors and selective antagonists for P2Y₄ and P2Y₁₄ receptors have not yet been identified. The P2Y₁₄ receptor appears to be the most restrictive of the class with respect to modification of the nucleobase, ribose, and phosphate moieties. The continuing process of ligand design for the P2Y receptors will aid in the identification of new clinical targets.